SCHEMBL13710177

SCHEMBL13710177

Cc1sc(-c2ccc(Cl)cc2)nc1C1=C(O)C2(CCCCC2)CCC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APEX1 P27695 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HRH3 Q9Y5N1 5/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ RARA P10276 2/20 0.36
▸ RARB P10826 2/20 0.36
▸ RARG P13631 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ TRPM8 Q7Z2W7 1/20 0.35
▸ CDC7 O00311 1/20 0.35
▸ DBF4 Q9UBU7 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CASP3 P42574 1/20 0.34
▸ SENP8 Q96LD8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13710167 0.90 APEX1 (0.41) APEX1ALDH1A1KMT2AHRH3RAB9A
SCHEMBL13761047 0.83 APEX1 (0.39) APEX1ALDH1A1KMT2AHRH3RAB9A
SCHEMBL13761049 0.83 APEX1 (0.41) APEX1ALDH1A1KMT2AHRH3RAB9A
SCHEMBL13710221 0.79 APEX1 (0.44) APEX1ALDH1A1KMT2ARAB9ASMN1; SMN2
SCHEMBL13712403 0.75 APEX1 (0.37) APEX1KMT2AHRH3RAB9ASMN1; SMN2
SCHEMBL13710236 0.73 WRN (0.47) APEX1ALDH1A1KMT2ARAB9ASMN1; SMN2
SCHEMBL1160635 0.73 APEX1 (0.44) APEX1ALDH1A1KMT2AHRH3RAB9A
SCHEMBL13710222 0.71 KMT2A (0.40) APEX1ALDH1A1KMT2AHRH3KDM4E
SCHEMBL13710231 0.71 HRH3 (0.46) ALDH1A1HRH3RAB9ASMN1; SMN2KDM4E
SCHEMBL13761088 0.70 APEX1 (0.45) APEX1ALDH1A1KMT2ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595404-B2 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents BAYER CROPSCIENCE AG (DE) 2009-09-29 — — US disclosed
US-7595404-B2 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents BAYER CROPSCIENCE AG (DE) 2009-09-29 — — US disclosed
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-06-14 — — US disclosed
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents DDT, CYP4B1, CYP1B1 APEX1 1912/4885ALDH1A1 620/4885KMT2A 2192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback